Your browser doesn't support javascript.
loading
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.
Molica, Stefano; Giannarelli, Diana; Visentin, Andrea; Reda, Gianluigi; Sportoletti, Paolo; Frustaci, Anna Maria; Chiarenza, Annalisa; Ciolli, Stefania; Vitale, Candida; Laurenti, Luca; De Paoli, Lorenzo; Murru, Roberta; Gentile, Massimo; Moia, Riccardo; Rigolin, Gian Matteo; Levato, Luciano; Giordano, Annamaria; Del Poeta, Giovanni; Stelitano, Caterina; Deodato, Marina; Ielo, Claudia; Noto, Alessandro; Guarente, Valerio; Coscia, Marta; Tedeschi, Alessandra; Gaidano, Gianluca; Cuneo, Antonio; Foa', Robin; Trentin, Livio; Mauro, Francesca Romana.
Afiliação
  • Molica S; Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
  • Giannarelli D; Biostatistic Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Reda G; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Sportoletti P; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine, University of Perugia, Perugia, Italy.
  • Frustaci AM; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda Milano, Milan, Italy.
  • Chiarenza A; Division of Hematology, Ferrarotto Hospital, Catania, Italy.
  • Ciolli S; Hematology Unit, Careggi Hospital, Florence, Italy.
  • Vitale C; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Laurenti L; Institute of Haematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • De Paoli L; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Murru R; Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco AO Brotzu, Cagliari, Italy.
  • Gentile M; Hematology Unit, Hematology and Oncology Department, Cosenza, Italy.
  • Moia R; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Rigolin GM; Hematology, Department of Medical Sciences, St. Anna University Hospital, Ferrara, Italy.
  • Levato L; Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
  • Giordano A; Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy.
  • Del Poeta G; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
  • Stelitano C; Department Hematology, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
  • Deodato M; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda Milano, Milan, Italy.
  • Ielo C; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Noto A; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Guarente V; Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine, University of Perugia, Perugia, Italy.
  • Coscia M; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Tedeschi A; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda Milano, Milan, Italy.
  • Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Cuneo A; Hematology, Department of Medical Sciences, St. Anna University Hospital, Ferrara, Italy.
  • Foa' R; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Trentin L; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Mauro FR; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
Am J Hematol ; 97(5): E176-E180, 2022 05.
Article em En | MEDLINE | ID: mdl-35170793
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article